Literature DB >> 8787956

Description of a new quotient that may differentiate blood pressure profiles in essential versus Cushing's syndrome-related hypertension.

P Stiefel1, J Gimenez, M L Miranda, A Leal-Cerro, O Muñiz, E Pamies, V Martín-Sanz, J Villar, J Carneado.   

Abstract

Since the presence or absence of a nocturnal decrease in blood pressure values (BP) may suggest an increased risk of visceral complications or the existence of secondary hypertension, several methods have been described for evaluating the BP profile. Nevertheless, a universally accepted system to evaluate this item has not yet been established. Our aim in this study was to test different dispersion quotients (DQ) which estimate the differences between the mean of each hour, and the mean of all the readings in the 24 h period. These quotients may be employed regarding systolic (SBP) or diastolic (DBP) blood pressure, and may be referred to the whole period of 24 h, or to the subperiods morning (m), afternoon (a) or night (n). We have studied two non selected groups of essential (n = 20) or secondary (Cushing's syndrome, n = 17) hypertensives. We observed a marked decrease in these quotients, particularly DQ-SBP and nDQ-SBP, in secondary hypertensives (respectively 10.2 +/- 2.9 vs 15.6 +/- 4.2 and 11.8 +/- 5.0 vs 20.5 +/- 6.3, p < 0.0001), thus indicating, a blunted nocturnal fall of BP in these patients. Also the DQ and particularly DQ-SBP, nDQ-SBP and nDQ-DBP, showed a high positive and negative predictive value, sensitivity and specificity for pertaining to the Cushing's syndrome group (respectively: 0.75, 0.88, 0.88, 0.75; 0.86, 0.82, 0.77 0.90; and 0.78, 0.84, 0.82, 0.80).

Entities:  

Mesh:

Year:  1995        PMID: 8787956     DOI: 10.1007/BF03349812

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Smoothing twenty-four-hour ambulatory blood pressure profiles: a comparison of alternative methods.

Authors:  B Streitberg; W Meyer-Sabellek
Journal:  J Hypertens Suppl       Date:  1990-12

2.  Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring.

Authors:  D Rizzoni; M L Muiesan; G Montani; R Zulli; S Calebich; E Agabiti-Rosei
Journal:  Am J Hypertens       Date:  1992-03       Impact factor: 2.689

Review 3.  Circadian blood pressure variations and their impact on disease.

Authors:  G Mancia; G Parati; F Albini; A Villani
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

4.  Twenty-four-hour blood pressure is not dependent on endogenous circadian rhythm.

Authors:  P Baumgart; P Walger; G Fuchs; K G Dorst; H Vetter; K H Rahn
Journal:  J Hypertens       Date:  1989-04       Impact factor: 4.844

5.  Direct arterial pressure, heart rate, and electrocardiogram in unrestricted patients before and after removal of a phaeochromocyoma.

Authors:  W A Littler; A J Honour
Journal:  Q J Med       Date:  1974-07

6.  A new approach for evaluating circadian blood pressure levels and variability from 24 h ambulatory blood pressure profiles.

Authors:  T Machnig; G Engels; S Schöbel; J Gellert; K Bachmann
Journal:  Am J Hypertens       Date:  1993-03       Impact factor: 2.689

7.  Sleep and blood pressure.

Authors:  W A Littler; A J Honour; R D Carter; P Sleight
Journal:  Br Med J       Date:  1975-08-09

8.  A quantitative analysis of the effects of activity and time of day on the diurnal variations of blood pressure.

Authors:  L A Clark; L Denby; D Pregibon; G A Harshfield; T G Pickering; S Blank; J H Laragh
Journal:  J Chronic Dis       Date:  1987

9.  Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations.

Authors:  Y Imai; K Abe; S Sasaki; N Minami; M Munakata; M Nihei; H Sekino; K Yoshinaga
Journal:  J Hypertens       Date:  1989-02       Impact factor: 4.844

10.  Diurnal variations of blood pressure and microalbuminuria in essential hypertension.

Authors:  S Bianchi; R Bigazzi; G Baldari; G Sgherri; V M Campese
Journal:  Am J Hypertens       Date:  1994-01       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.